A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family‐based study
Authors:
Open Access
- 2 January 2018
- journal article
- research article
- Published by Wiley in Clinical Otolaryngology
- Vol. 43 (3) , 841-845
Abstract
Objective: In the Netherlands, the majority of hereditary head and neck paragangliomas (HNPGL) are caused by germline variants in the succinate dehydrogenase genes (SDHD, SDHB, SDHAF2). Here, we evaluate a four‐generation family linked to a novel SDHB gene variant with the manifestation of a HNPGL.Design: A family‐based study.Setting: The VU University Medical Center (VUmc) Amsterdam, a tertiary clinic for Otolaryngology and Head and Neck Surgery.Participants and main outcome measures: The index patients presented with an embryonic rhabdomyosarcoma and a non‐Hodgkin lymphoma. Array‐based comparative genomic hybridisation (aCGH) analysis and multiplex ligation‐dependent probe amplification (MLPA) revealed a novel deletion of exon 1‐3 in the SDHB gene, suspected to predispose to paraganglioma (PGL)/pheochromocytoma (PHEO) syndrome type 4. Subsequently, genetic counselling and DNA testing were offered to all family members at risk. Individuals that tested positive for this novel SDHB gene variant were counselled and additional clinical evaluation was offered for the identification of HNPGL and/or PHEO.Results: The DNA of 18 family members was tested, resulting in the identification of 10 carriers of the exon 1‐3 deletion in the SDHB gene. One carrier was diagnosed with a carotid body PGL and serum catecholamine excess, which was surgically excised. Negative SDHB immunostaining of the carotid body tumour confirmed that it was caused by the SDHB variant. The remaining 9 carriers showed no evidence of PGL/PHEO.Conclusion: Deletion of exon 1‐3 in the SDHB gene is a novel germline variant associated with the formation of hereditary HNPGL.Keywords
This publication has 19 references indexed in Scilit:
- Are we overestimating the penetrance of mutations in SDHB?Human Mutation, 2010
- Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations inSDHBandSDHDHuman Mutation, 2009
- The first Dutch SDHB founder deletion in paraganglioma – pheochromocytoma patientsBMC Medical Genetics, 2009
- Penetrance and clinical consequences of a gross SDHB deletion in a large familyClinical Genetics, 2009
- Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma SyndromesThe Journal of Clinical Endocrinology & Metabolism, 2006
- Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: A possible hot spot?Genes, Chromosomes and Cancer, 2005
- Distinct Clinical Features of Paraganglioma Syndromes Associated With SDHB and SDHD Gene MutationsJAMA, 2004
- Early-Onset Renal Cell Carcinoma as a Novel Extraparaganglial Component of SDHB-Associated Heritable ParagangliomaThe American Journal of Human Genetics, 2004
- Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial ParagangliomaThe American Journal of Human Genetics, 2001
- Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary ParagangliomaScience, 2000